New Delhi: The Government of India has slashed the price of
Remdesivir from Rs. 5,400 to Rs. 3,500 for the benefit of Corona patients and has supplied 6.69 lakh bottles to various States in the last five days, said Union Minister for Chemicals and Fertilizers D.V. Sadananda Gowda (DVS).
He held a meeting with Mansukh Mandaviya, Minister of State for Chemicals and Fertilizers, S. Aparna, Secretary, Department of Pharmaceutical, Shubra Singh, Chairwoman, National Pharmaceutical Pricing Authority, Dr. V.G. Somani, Drug Controller General of India and Subodh Kumar, Personal Secretary here regarding production and distribution of Corona connected drugs.
Later, in a press release, DVS said the manufacturing of Remdesivir had been increased from 28.63 lakh bottles to 41 lakh bottles per month. Steps had been taken to step up production of medicines used in the treatment of Corona, especially Remdesivir. Six Pharmaceutical companies have bagged licence to manufacture Remdesivir inj
Pharma companies cut Remdesivir injection prices on govt intervention: NPPA
Drug companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have cut the prices of their respective brands of Remdesivir injection (100 mg/vial).
Share Via Email
| A+A A-
Vials of remdesivir injections recovered from three persons who were arrested by the police for its alleged black marketing, in Kanpur. (Photo | PTI) By PTI
NEW DELHI: Prices of
Remdesivir injection have been voluntarily curtailed by various drug companies on the intervention of the government, National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
Drug companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have cut the prices of their respective brands of Remdesivir injection (100 mg/vial).
Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the life-saver Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per injection now, according to official sources. In a missive late on Friday, the Ministry of Chemicals & Fertilisers, Department of Pharmaceuticals, NPPA - Advisor (Costs) N.I. Chowdhury has ordered all pharma companies to comply with the revised norms with immediate and retrospective effect. Based on the Form-V furnished regarding voluntary reduction in Maximum Retail Price (MRP) of Remdesivir, Manufacturers/Marketers of the Remdesivir are hereby directed to implement the revised MRP throughout the distribution chain w.e.f. 15.04.2021, irrespective of the batch numbers, the stern notification said.
Mansukh Mandaviya, NCP leader Malik spar over availability of remdesivir
SECTIONS
Last Updated: Apr 17, 2021, 06:46 PM IST
Share
Synopsis
A war of words broke out between Union Minister Mansukh L Mandaviya and NCP leader Nawab Malik on Saturday on the availability of antiviral drug remdesivir, which is used in the treatment of COVID-19.
A war of words broke out between Union Minister Mansukh L Mandaviya and NCP leader Nawab Malik on Saturday on the availability of antiviral drug remdesivir, which is used in the treatment of COVID-19. Malik, in a series of tweets, alleged that the central government is not giving permission to various export-oriented units (EoUs) in the country to sell the drug in the domestic market.
Government slashes Remdesivir MRP by half, with retro-effect indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.